FDA Import Refusal 799-0323626-4/21/1 — NOVO NORDISK

NOVO NORDISK — FEI 3014158939

The FDA refused shipment 799-0323626-4/21/1 from NOVO NORDISK (Canada) on Apr 24, 2024. The refused product falls under Drugs and Biologics — ISOPHANE INSULIN (SUSP) (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.